. Author manuscript; available in PMC: 2013 May 16.

Published in final edited form as: Endocr Res. 2012 May 16;37(4):203–215. doi: 10.3109/07435800.2012.668254

Table 1.

Microarray datasets used for analysis. All animals were between 10 and 12 weeks of age at the start of the study. Animals were oriechtomized (ORX) or ovariectomized (OVX) and then treated with DHT after the indicated amount of time. The tissues were harvested following DHT treatment for the indicated amount of time.

Species/Age/Tissue	Treatment	Reference
SD rat/10wks/Prostate	ORX 3d; 10mg/kg DHT IP 16h	GSE29170
SD rat/10wks/Forebrain	ORX 3d; 10mg/kg DHT IP 16h	GSE29170
SD rat/10wks/Ovary	ORX 3d; 10mg/kg DHT IP 16h	GSE29170
SD rat/10wks/Skin	ORX 3d; 10mg/kg DHT IP 16h	GSE29170
SD rat/10wks/Prostate	ORX 3d; 3mg/kg DHT IP 24h	(33)
SD rat/12wks/Uterus	OVX 3w; 3mg/kg DHT IP 24h	(34)
SD rat/10wks/Muscle	ORX 11w; 3mg/kg DHT IP 24h	(39)

SD=Sprague Dawley